CIGX is putting together a new uptrend since pulling back from its April highs in excess of $5 per share. The indicators are aligning and the chart is hitting our watchlist for continuation. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:
Today before the opening bell, Max Media Group, Inc. announced several updates. As reported previously, the company has entered into multiple Letter of Intents for various acquisitions. Max Media is currently finalizing the terms and conditions regarding B2LIVE and The Golden Voice, anticipating the deals to proceed to definitive agreements over the next few days. CEO Jim Grady stated, "It is our intention to aggressively take advantage of the huge discrepancy in the market for buying and selling smaller websites (generally with price tags under $1 million). By acquiring smaller sites at the lower multiples and networking them together under…
NovaBay Pharmaceuticals Inc., a clinical-stage biotech company developing compounds to fight bacteria, fungi and viruses, presented a poster at the 2011 Conference of the Association for Research in Vision and Ophthalmology (ARVO) held this week in Fort Lauderdale, Fla. The poster, titled “Aganocide® Compounds Effective Against Ophthalmic Pathogens,” highlights three new Aganocide compounds similar to NovaBay’s lead anti-infective Aganocide compound, NVC-422. Novabay’s NVC-727, NVC-638, and NVC-704 compounds are broad-spectrum, fast-acting antimicrobial agents designed with the same mechanism of action but different activity profiles. The three new compounds expand Novabay’s current portfolio of Aganocide compounds and open a door for the…
PhotoMedex, Inc., an industry leader of clinical skincare and laser products, introduced their innovative DNA Damage Control product. This product is much different than typical treatments and sunscreens in that it uses DNA to repair damaged skin. This product is being marketed under the company's NEOVA brand. DNA Damage Control defends against photodamage by boosting the body’s natural DNA repair process. The patent-pending formulas use liposomes to deliver DNA repair enzymes to the cellular level of the skin, hyper-targeting the site of the DNA injury. Clinical studies have shown that DNA repair enzymes reduced DNA damage by 45% and increased…
DUSA Pharmaceuticals Inc., a dermatology company developing and marketing products focused on patients with common skin conditions, Friday posted its first-quarter financials, reporting a 27 percent earnings increase. Revenues for the first quarter of 2011 were $11.1 million, up 27 percent compared to $8.7 million reported for the comparable quarter of 2010. The company widened its net loss for the quarter at $0.6 million, or $(0.02) per common share, compared to a net loss of $0.4 million, or ($0.02) per common share, in the first quarter of the year prior. As of March 31, 2011, the company had total cash,…
Max Media Group, Inc. is focused on providing monetized content to high-end, high impact social-based online community markets. Anyone, anywhere, can upload breaking news stories and high-end luxury items for sale by text, photo, or video through cell phones or other mobile devices on the Max Media Group's growing network of web sites. The company has formed an aggressive growth strategy to capture audiences and revenue through acquisitions and development of low cost of entry, rich interactive platforms in the highest valued advertising demographics. Max Media intends to leverage and monetize all of its websites through content and affiliate marketing. Today's…
We have observed an influx of emails spamming EcoEmissions Solutions, Inc. from various free email accounts over the weekend. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics…
Solta Medical reported today reception of FDA 501k clearance for the Company’s Clear + Brilliant treatment, which had previously received CE mark and is based on SLTM’s fractional laser technology. The Clear + Brilliant treatment will be officially launched at the upcoming World Congress of Dermatology in Seoul, Korea. The advent of this new treatment would not have been possible without the Company’s mastery of fractional laser applications, as evident in SLTM’s Fraxel® treatment, which delivers minimally invasive clinical solutions for resurfacing aging/sun damaged skin. The Company started shipping the product to select/key international markets back in April and has…
Located in China, SinoTech has rapidly evolved as a provider of enhanced oil recovery (“EOR”) services. Today, the company announced an updated financial outlook for fiscal year 2011. SinoTech also told investors that it will release its unaudited financial results for the second quarter ended March 31, 2011, on May 19, 2011. Based on current business and operating conditions, SinoTech expects to report total sales in the range of US$100 million to US$105 million in fiscal year 2011. The numbers greatly exceed the previously announced range of US$90 million to US$95 million. Leading the way at SinoTech is Mr. Boxun…
DUSA Pharmaceuticals Inc., a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, reported a 27 percent increase in first-quarter revenues. “We are off to a great start in 2011,” Robert Doman, president and CEO of the DUSA stated in the press release. “Continued growth of our core domestic PDT revenues, as well as record gross margins, drove significant year-over-year improvement in our non-GAAP profitability and cash flow.” Total product revenues for the first quarter were $11.1 million, up 27 percent from $8.7 million in the first quarter…
QualityStocks is powered by IBNAi
Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.
Copyright © .
